This report contains market size and forecasts of Dolutegravir in global, including the following market information:
Global Dolutegravir Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dolutegravir Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Dolutegravir companies in 2021 (%)
The global Dolutegravir market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10mg Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dolutegravir include ViiV Healthcare (GSK), Shanghai Desano Pharmaceuticals, Mylan, Aurobindo Pharma, LAURUS Labs and Adcock Ingram Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dolutegravir manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dolutegravir Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Dolutegravir Market Segment Percentages, by Type, 2021 (%)
10mg Tablets
50mg Tablets
Global Dolutegravir Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Dolutegravir Market Segment Percentages, by Application, 2021 (%)
Prevent HIV Infection Following Potential Exposure
Other
Global Dolutegravir Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Dolutegravir Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dolutegravir revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dolutegravir revenues share in global market, 2021 (%)
Key companies Dolutegravir sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Dolutegravir sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ViiV Healthcare (GSK)
Shanghai Desano Pharmaceuticals
Mylan
Aurobindo Pharma
LAURUS Labs
Adcock Ingram Limited